Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

ConditionsPsoriasis Cardiovascular Diseases Cardiovascular Risk Factor Cardiovascular Pathology Psoriasis Vulgaris Psoriatic Nail Psoriasis Face Psoriasis Guttate Psoriasis Gyrata Psoriasis Diffusa Psoriasis Palmaris Psoriasis Annularis Psoriasis Circinata Psoriasis Plantaris Psoriasis Universalis Psoriasis Geographica Left Ventricular Dysfunction Myocardial Infarction Myocardial Ischemia Heart Failure Stroke Heart Diseases Heart Failure, Systolic Heart Failure, Diastolic

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorHerlev and Gentofte Hospital

About this trial

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.

Eligibility criteria

Qualifiers

Patients 18 years or older with a diagnosis of psoriasis will be invited to participate

Disqualifiers

Patients not able to cooperate to the study

Patients unable understand and sign informed consent

Trial design

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants

are grouped into 2 trial groups

Sponsors and collaborators

Herlev and Gentofte Hospital

Lead sponsor

Source ClinicalTrials.gov